[Considerations on clinical trial issues related to new drug development for metabolic and alcohol-associated liver disease and fatty liver disease].
- DOI
- 10.3760/cma.j.cn501113-20260303-00085
- Published
- 2026 Aug 20
- Container
- Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3760/cma.j.cn501113-20260303-00085,
title = {[Considerations on clinical trial issues related to new drug development for metabolic and alcohol-associated liver disease and fatty liver disease].},
author = {Wang XY and Sun HM and Gao YH},
year = {2026},
journal = {Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology},
doi = {10.3760/cma.j.cn501113-20260303-00085},
url = {https://doi.org/10.3760/cma.j.cn501113-20260303-00085}
}RIS
TY - JOUR TI - [Considerations on clinical trial issues related to new drug development for metabolic and alcohol-associated liver disease and fatty liver disease]. AU - Wang XY AU - Sun HM AU - Gao YH PY - 2026 JO - Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology DO - 10.3760/cma.j.cn501113-20260303-00085 UR - https://doi.org/10.3760/cma.j.cn501113-20260303-00085 ER -
APA
XY, W., HM, S., & YH, G. (2026). [Considerations on clinical trial issues related to new drug development for metabolic and alcohol-associated liver disease and fatty liver disease].. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. https://doi.org/10.3760/cma.j.cn501113-20260303-00085
Source records
- pubmed · retrieved 2026-09-26T23:37:13.090Z